scispace - formally typeset
W

Weizhi Ji

Researcher at Kunming University of Science and Technology

Publications -  161
Citations -  5790

Weizhi Ji is an academic researcher from Kunming University of Science and Technology. The author has contributed to research in topics: Embryonic stem cell & Cellular differentiation. The author has an hindex of 30, co-authored 141 publications receiving 4766 citations. Previous affiliations of Weizhi Ji include Chinese Academy of Sciences & World Economic Forum.

Papers
More filters
Journal ArticleDOI

Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos

TL;DR: By coinjection of Cas9 mRNA and sgRNAs into one-cell-stage embryos, this system successfully achieves precise gene targeting in cynomolgus monkeys and enables simultaneous disruption of two target genes in one step, and no off-target mutagenesis was detected by comprehensive analysis.
Journal ArticleDOI

Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated Immunosuppression

TL;DR: Bone marrow‐derived mesenchymal stem cells (MSCs) hold great promise for treating immune disorders because of their immunoregulatory capacity, but the mechanism remains controversial, as it is shown here, the mechanism of MSC‐mediated immunosuppression varies among different species.
Journal ArticleDOI

Generation of Induced Pluripotent Stem Cells from Adult Rhesus Monkey Fibroblasts

TL;DR: In this article, a retrovirus-mediated introduction of monkey transcription factors OCT4, SOX2, KLF4, and c-MYC was used to generate monkey induced pluripotent stem cells.
Journal ArticleDOI

A developmental landscape of 3D-cultured human pre-gastrulation embryos.

TL;DR: A 3D culture system to model human embryonic development, together with single-cell transcriptome profiling, provides insights into the molecular developmental landscape during human post-implantation embryogenesis.
Journal ArticleDOI

Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9

TL;DR: The findings indicate that CRISPR/Cas9 can efficiently generate monkey models of human diseases, regardless of inheritance patterns, and the presence of degenerated muscle cells in newborn Cas9-targeted monkeys suggests that therapeutic interventions at the early disease stage may be effective at alleviating the myopathy.